In that series, VEGF-C was secreted by the intraductal carcinoma cells and was suggested to act as a growth factor for Flt-4-positive periductal blood vessels and (less evidently) for lymphatic vessels (Valtola et al, 1999). The gene discussed is FLT4; the disease is carcinoma.